共 50 条
- [1] Inactivation of PI(3)K p110δ breaks regulatory T-cell-mediated immune tolerance to cancer[J]. NATURE, 2014, 510 (7505) : 407 - +Ali, Khaled论文数: 0 引用数: 0 h-index: 0机构: UCL, UCL Canc Inst, London WC1E 6DD, England UCL, UCL Canc Inst, London WC1E 6DD, EnglandSoond, Dalya R.论文数: 0 引用数: 0 h-index: 0机构: Babraham Inst, Lab Lymphocyte Signalling & Dev, Cambridge CB22 3AT, England UCL, UCL Canc Inst, London WC1E 6DD, EnglandPineiro, Roberto论文数: 0 引用数: 0 h-index: 0机构: UCL, UCL Canc Inst, London WC1E 6DD, England UCL, UCL Canc Inst, London WC1E 6DD, EnglandHagemann, Thorsten论文数: 0 引用数: 0 h-index: 0机构: Queen Mary Univ London, Barts Canc Inst, Ctr Canc & Inflammat, London EC1M 6BQ, England UCL, UCL Canc Inst, London WC1E 6DD, EnglandPearce, Wayne论文数: 0 引用数: 0 h-index: 0机构: UCL, UCL Canc Inst, London WC1E 6DD, England UCL, UCL Canc Inst, London WC1E 6DD, EnglandLim, Ee Lyn论文数: 0 引用数: 0 h-index: 0机构: Babraham Inst, Lab Lymphocyte Signalling & Dev, Cambridge CB22 3AT, England UCL, UCL Canc Inst, London WC1E 6DD, EnglandBouabe, Hicham论文数: 0 引用数: 0 h-index: 0机构: Babraham Inst, Lab Lymphocyte Signalling & Dev, Cambridge CB22 3AT, England UCL, UCL Canc Inst, London WC1E 6DD, EnglandScudamore, Cheryl L.论文数: 0 引用数: 0 h-index: 0机构: MRC Harwell, Mary Lyon Ctr, Harwell OX11 0RD, Berks, England UCL, UCL Canc Inst, London WC1E 6DD, EnglandHancox, Timothy论文数: 0 引用数: 0 h-index: 0机构: Piramed Pharma, Slough SL1 4NL, Berks, England UCL, UCL Canc Inst, London WC1E 6DD, EnglandMaecker, Heather论文数: 0 引用数: 0 h-index: 0机构: Genentech Inc, Canc Signaling & Translat Oncol, San Francisco, CA 94080 USA UCL, UCL Canc Inst, London WC1E 6DD, EnglandFriedman, Lori论文数: 0 引用数: 0 h-index: 0机构: Genentech Inc, Canc Signaling & Translat Oncol, San Francisco, CA 94080 USA UCL, UCL Canc Inst, London WC1E 6DD, EnglandTurner, Martin论文数: 0 引用数: 0 h-index: 0机构: Babraham Inst, Lab Lymphocyte Signalling & Dev, Cambridge CB22 3AT, England UCL, UCL Canc Inst, London WC1E 6DD, EnglandOkkenhaug, Klaus论文数: 0 引用数: 0 h-index: 0机构: Babraham Inst, Lab Lymphocyte Signalling & Dev, Cambridge CB22 3AT, England UCL, UCL Canc Inst, London WC1E 6DD, EnglandVanhaesebroeck, Bart论文数: 0 引用数: 0 h-index: 0机构: UCL, UCL Canc Inst, London WC1E 6DD, England UCL, UCL Canc Inst, London WC1E 6DD, England
- [2] Inactivation of PI(3)K p110δ breaks regulatory T-cell-mediated immune tolerance to cancer[J]. Nature, 2014, 510 : 407 - 411Khaled Ali论文数: 0 引用数: 0 h-index: 0机构: UCL Cancer Institute,Dalya R. Soond论文数: 0 引用数: 0 h-index: 0机构: UCL Cancer Institute,Roberto Piñeiro论文数: 0 引用数: 0 h-index: 0机构: UCL Cancer Institute,Thorsten Hagemann论文数: 0 引用数: 0 h-index: 0机构: UCL Cancer Institute,Wayne Pearce论文数: 0 引用数: 0 h-index: 0机构: UCL Cancer Institute,Ee Lyn Lim论文数: 0 引用数: 0 h-index: 0机构: UCL Cancer Institute,Hicham Bouabe论文数: 0 引用数: 0 h-index: 0机构: UCL Cancer Institute,Cheryl L. Scudamore论文数: 0 引用数: 0 h-index: 0机构: UCL Cancer Institute,Timothy Hancox论文数: 0 引用数: 0 h-index: 0机构: UCL Cancer Institute,Heather Maecker论文数: 0 引用数: 0 h-index: 0机构: UCL Cancer Institute,Lori Friedman论文数: 0 引用数: 0 h-index: 0机构: UCL Cancer Institute,Martin Turner论文数: 0 引用数: 0 h-index: 0机构: UCL Cancer Institute,Klaus Okkenhaug论文数: 0 引用数: 0 h-index: 0机构: UCL Cancer Institute,Bart Vanhaesebroeck论文数: 0 引用数: 0 h-index: 0机构: UCL Cancer Institute,
- [3] Correction: Corrigendum: Inactivation of PI(3)K p110δ breaks regulatory T-cell-mediated immune tolerance to cancer[J]. Nature, 2016, 535 : 580 - 580Khaled Ali论文数: 0 引用数: 0 h-index: 0Dalya R. Soond论文数: 0 引用数: 0 h-index: 0Roberto Piñeiro论文数: 0 引用数: 0 h-index: 0Thorsten Hagemann论文数: 0 引用数: 0 h-index: 0Wayne Pearce论文数: 0 引用数: 0 h-index: 0Ee Lyn Lim论文数: 0 引用数: 0 h-index: 0Hicham Bouabe论文数: 0 引用数: 0 h-index: 0Cheryl L. Scudamore论文数: 0 引用数: 0 h-index: 0Timothy Hancox论文数: 0 引用数: 0 h-index: 0Heather Maecker论文数: 0 引用数: 0 h-index: 0Lori Friedman论文数: 0 引用数: 0 h-index: 0Martin Turner论文数: 0 引用数: 0 h-index: 0Klaus Okkenhaug论文数: 0 引用数: 0 h-index: 0Bart Vanhaesebroeck论文数: 0 引用数: 0 h-index: 0
- [4] The PI3Ks p110α and p110δ control regulatory T cell function[J]. IMMUNOLOGY, 2011, 135 : 54 - 54Slack, E. C. M.论文数: 0 引用数: 0 h-index: 0机构: Babraham Inst, Cambridge, England Univ London Royal Vet Coll, London, England Babraham Inst, Cambridge, EnglandSoond, D. R.论文数: 0 引用数: 0 h-index: 0机构: Babraham Inst, Cambridge, England Babraham Inst, Cambridge, EnglandScudamore, C. L.论文数: 0 引用数: 0 h-index: 0机构: Univ London Royal Vet Coll, London, England Babraham Inst, Cambridge, EnglandGarden, O. A.论文数: 0 引用数: 0 h-index: 0机构: Univ London Royal Vet Coll, London, England Babraham Inst, Cambridge, England论文数: 引用数: h-index:机构:
- [5] PI3K p110δ inactivation antagonizes chronic lymphocytic leukemia and reverses T cell immune suppression[J]. JOURNAL OF CLINICAL INVESTIGATION, 2019, 129 (01): : 122 - 136Dong, Shuai论文数: 0 引用数: 0 h-index: 0机构: Ohio State Univ, Coll Pharm, Div Pharmaceut & Pharmaceut Chem, 500 W 12Th Ave, Columbus, OH 43210 USA Ohio State Univ, Dept Internal Med, Div Hematol, Columbus, OH 43210 USA Ohio State Univ, Ctr Comprehens Canc, 455 Wiseman Hall,410 West 12th Ave, Columbus, OH 43210 USA Ohio State Univ, Coll Pharm, Div Pharmaceut & Pharmaceut Chem, 500 W 12Th Ave, Columbus, OH 43210 USAHarrington, Bonnie K.论文数: 0 引用数: 0 h-index: 0机构: Ohio State Univ, Dept Internal Med, Div Hematol, Columbus, OH 43210 USA Ohio State Univ, Ctr Comprehens Canc, 455 Wiseman Hall,410 West 12th Ave, Columbus, OH 43210 USA Ohio State Univ, Coll Vet Med, Columbus, OH 43210 USA Ohio State Univ, Coll Pharm, Div Pharmaceut & Pharmaceut Chem, 500 W 12Th Ave, Columbus, OH 43210 USAHu, Eileen Y.论文数: 0 引用数: 0 h-index: 0机构: Ohio State Univ, Dept Internal Med, Div Hematol, Columbus, OH 43210 USA Ohio State Univ, Ctr Comprehens Canc, 455 Wiseman Hall,410 West 12th Ave, Columbus, OH 43210 USA Ohio State Univ, Med Scientist Training Program, Columbus, OH 43210 USA Ohio State Univ, Coll Pharm, Div Pharmaceut & Pharmaceut Chem, 500 W 12Th Ave, Columbus, OH 43210 USAGreene, Joseph T.论文数: 0 引用数: 0 h-index: 0机构: Ohio State Univ, Dept Internal Med, Div Hematol, Columbus, OH 43210 USA Ohio State Univ, Ctr Comprehens Canc, 455 Wiseman Hall,410 West 12th Ave, Columbus, OH 43210 USA Ohio State Univ, Mol Cellular & Dev Biol Program, Columbus, OH 43210 USA Ohio State Univ, Coll Pharm, Div Pharmaceut & Pharmaceut Chem, 500 W 12Th Ave, Columbus, OH 43210 USALehman, Amy M.论文数: 0 引用数: 0 h-index: 0机构: Ohio State Univ, Ctr Biostat, Columbus, OH 43210 USA Ohio State Univ, Coll Pharm, Div Pharmaceut & Pharmaceut Chem, 500 W 12Th Ave, Columbus, OH 43210 USAMinh Tran论文数: 0 引用数: 0 h-index: 0机构: Ohio State Univ, Dept Internal Med, Div Hematol, Columbus, OH 43210 USA Ohio State Univ, Ctr Comprehens Canc, 455 Wiseman Hall,410 West 12th Ave, Columbus, OH 43210 USA Ohio State Univ, Coll Pharm, Div Pharmaceut & Pharmaceut Chem, 500 W 12Th Ave, Columbus, OH 43210 USAWasmuth, Ronni L.论文数: 0 引用数: 0 h-index: 0机构: Ohio State Univ, Dept Internal Med, Div Hematol, Columbus, OH 43210 USA Ohio State Univ, Ctr Comprehens Canc, 455 Wiseman Hall,410 West 12th Ave, Columbus, OH 43210 USA Ohio State Univ, Coll Pharm, Div Pharmaceut & Pharmaceut Chem, 500 W 12Th Ave, Columbus, OH 43210 USALong, Meixiao论文数: 0 引用数: 0 h-index: 0机构: Ohio State Univ, Dept Internal Med, Div Hematol, Columbus, OH 43210 USA Ohio State Univ, Ctr Comprehens Canc, 455 Wiseman Hall,410 West 12th Ave, Columbus, OH 43210 USA Ohio State Univ, Coll Pharm, Div Pharmaceut & Pharmaceut Chem, 500 W 12Th Ave, Columbus, OH 43210 USAMuthusamy, Natarajan论文数: 0 引用数: 0 h-index: 0机构: Ohio State Univ, Dept Internal Med, Div Hematol, Columbus, OH 43210 USA Ohio State Univ, Ctr Comprehens Canc, 455 Wiseman Hall,410 West 12th Ave, Columbus, OH 43210 USA Ohio State Univ, Coll Pharm, Div Pharmaceut & Pharmaceut Chem, 500 W 12Th Ave, Columbus, OH 43210 USABrown, Jennifer R.论文数: 0 引用数: 0 h-index: 0机构: Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA Ohio State Univ, Coll Pharm, Div Pharmaceut & Pharmaceut Chem, 500 W 12Th Ave, Columbus, OH 43210 USAJohnson, Amy J.论文数: 0 引用数: 0 h-index: 0机构: Ohio State Univ, Dept Internal Med, Div Hematol, Columbus, OH 43210 USA Ohio State Univ, Ctr Comprehens Canc, 455 Wiseman Hall,410 West 12th Ave, Columbus, OH 43210 USA Janssen Res & Dev LLC, Spring House, PA USA Ohio State Univ, Coll Pharm, Div Pharmaceut & Pharmaceut Chem, 500 W 12Th Ave, Columbus, OH 43210 USAByrd, John C.论文数: 0 引用数: 0 h-index: 0机构: Ohio State Univ, Coll Pharm, Div Pharmaceut & Pharmaceut Chem, 500 W 12Th Ave, Columbus, OH 43210 USA Ohio State Univ, Dept Internal Med, Div Hematol, Columbus, OH 43210 USA Ohio State Univ, Ctr Comprehens Canc, 455 Wiseman Hall,410 West 12th Ave, Columbus, OH 43210 USA Ohio State Univ, Coll Pharm, Div Pharmaceut & Pharmaceut Chem, 500 W 12Th Ave, Columbus, OH 43210 USA
- [6] PI3K p110δ controls the differentiation and function of regulatory T cells[J]. IMMUNOLOGY, 2008, 125 : 129 - 129Patton, D. T.论文数: 0 引用数: 0 h-index: 0机构: Babraham Inst, Cambridge, England Babraham Inst, Cambridge, EnglandEmery, J. L.论文数: 0 引用数: 0 h-index: 0机构: Babraham Inst, Cambridge, England Babraham Inst, Cambridge, EnglandRowan, W. C.论文数: 0 引用数: 0 h-index: 0机构: GSK, Stevenage, Herts, England Babraham Inst, Cambridge, England论文数: 引用数: h-index:机构:
- [7] The PI3K p110δ Isoform Inhibitor Idelalisib Preferentially Inhibits Human Regulatory T Cell Function[J]. JOURNAL OF IMMUNOLOGY, 2019, 202 (05): : 1397 - 1405Chellappa, Stalin论文数: 0 引用数: 0 h-index: 0机构: Oslo Univ Hosp, Inst Canc Res, Dept Canc Immunol, POB 4953 Nydalen, N-0424 Oslo, Norway Univ Oslo, Inst Clin Med, KG Jebsen Ctr B Cell Malignancies, N-0424 Oslo, Norway Univ Oslo, Inst Clin Med, KG Jebsen Ctr Canc Immunotherapy, N-0424 Oslo, Norway Univ Oslo, Nord EMBL Partnership, Ctr Mol Med Norway, N-0318 Oslo, Norway Oslo Univ Hosp, Inst Canc Res, Dept Canc Immunol, POB 4953 Nydalen, N-0424 Oslo, NorwayKushekhar, Kushi论文数: 0 引用数: 0 h-index: 0机构: Oslo Univ Hosp, Inst Canc Res, Dept Canc Immunol, POB 4953 Nydalen, N-0424 Oslo, Norway Univ Oslo, Inst Clin Med, KG Jebsen Ctr B Cell Malignancies, N-0424 Oslo, Norway Univ Oslo, Inst Clin Med, KG Jebsen Ctr Canc Immunotherapy, N-0424 Oslo, Norway Univ Oslo, Nord EMBL Partnership, Ctr Mol Med Norway, N-0318 Oslo, Norway Oslo Univ Hosp, Inst Canc Res, Dept Canc Immunol, POB 4953 Nydalen, N-0424 Oslo, NorwayMunthe, Ludvig A.论文数: 0 引用数: 0 h-index: 0机构: Univ Oslo, Inst Clin Med, KG Jebsen Ctr B Cell Malignancies, N-0424 Oslo, Norway Oslo Univ Hosp, Dept Immunol & Transfus Med, N-0424 Oslo, Norway Oslo Univ Hosp, Inst Canc Res, Dept Canc Immunol, POB 4953 Nydalen, N-0424 Oslo, NorwayTjonnfjord, Geir E.论文数: 0 引用数: 0 h-index: 0机构: Univ Oslo, Inst Clin Med, KG Jebsen Ctr B Cell Malignancies, N-0424 Oslo, Norway Oslo Univ Hosp, Dept Haematol, N-0424 Oslo, Norway Oslo Univ Hosp, Inst Canc Res, Dept Canc Immunol, POB 4953 Nydalen, N-0424 Oslo, NorwayAandahl, Einar M.论文数: 0 引用数: 0 h-index: 0机构: Oslo Univ Hosp, Inst Canc Res, Dept Canc Immunol, POB 4953 Nydalen, N-0424 Oslo, Norway Univ Oslo, Inst Clin Med, KG Jebsen Ctr B Cell Malignancies, N-0424 Oslo, Norway Univ Oslo, Inst Clin Med, KG Jebsen Ctr Canc Immunotherapy, N-0424 Oslo, Norway Univ Oslo, Nord EMBL Partnership, Ctr Mol Med Norway, N-0318 Oslo, Norway Oslo Univ Hosp, Sect Transplantat Surg, N-0424 Oslo, Norway Oslo Univ Hosp, Inst Canc Res, Dept Canc Immunol, POB 4953 Nydalen, N-0424 Oslo, NorwayOkkenhaug, Klaus论文数: 0 引用数: 0 h-index: 0机构: Univ Cambridge, Dept Pathol, Cambridge CB2 1QP, England Oslo Univ Hosp, Inst Canc Res, Dept Canc Immunol, POB 4953 Nydalen, N-0424 Oslo, NorwayTasken, Kjetil论文数: 0 引用数: 0 h-index: 0机构: Oslo Univ Hosp, Inst Canc Res, Dept Canc Immunol, POB 4953 Nydalen, N-0424 Oslo, Norway Univ Oslo, Inst Clin Med, KG Jebsen Ctr B Cell Malignancies, N-0424 Oslo, Norway Univ Oslo, Inst Clin Med, KG Jebsen Ctr Canc Immunotherapy, N-0424 Oslo, Norway Univ Oslo, Nord EMBL Partnership, Ctr Mol Med Norway, N-0318 Oslo, Norway Oslo Univ Hosp, Inst Canc Res, Dept Canc Immunol, POB 4953 Nydalen, N-0424 Oslo, Norway
- [8] The PI3K subunits, P110α and P110β are potential targets for overcoming P-gp and BCRP-mediated MDR in cancer[J]. MOLECULAR CANCER, 2020, 19 (01)Zhang, Lei论文数: 0 引用数: 0 h-index: 0机构: Chinese Acad Sci, Fujian Inst Res Struct Matter, State Key Lab Struct Chem, Fuzhou 350002, Peoples R China St Johns Univ, Coll Pharm & Hlth Sci, Dept Pharmaceut Sci, Jamaica, NY 11439 USA Chinese Acad Sci, Fujian Inst Res Struct Matter, State Key Lab Struct Chem, Fuzhou 350002, Peoples R ChinaLi, Yidong论文数: 0 引用数: 0 h-index: 0机构: St Johns Univ, Coll Pharm & Hlth Sci, Dept Pharmaceut Sci, Jamaica, NY 11439 USA Chinese Acad Sci, Fujian Inst Res Struct Matter, State Key Lab Struct Chem, Fuzhou 350002, Peoples R ChinaWang, Qianchao论文数: 0 引用数: 0 h-index: 0机构: Chinese Acad Sci, Fujian Inst Res Struct Matter, State Key Lab Struct Chem, Fuzhou 350002, Peoples R China Chinese Acad Sci, Fujian Inst Res Struct Matter, State Key Lab Struct Chem, Fuzhou 350002, Peoples R ChinaChen, Zhuo论文数: 0 引用数: 0 h-index: 0机构: Chinese Acad Sci, Fujian Inst Res Struct Matter, State Key Lab Struct Chem, Fuzhou 350002, Peoples R China Chinese Acad Sci, Fujian Inst Res Struct Matter, State Key Lab Struct Chem, Fuzhou 350002, Peoples R ChinaLi, Xiaoyun论文数: 0 引用数: 0 h-index: 0机构: St Johns Univ, Coll Pharm & Hlth Sci, Dept Pharmaceut Sci, Jamaica, NY 11439 USA Jinan Univ, Coll Tradit Chinese Med, Guangzhou 510632, Guangdong, Peoples R China Chinese Acad Sci, Fujian Inst Res Struct Matter, State Key Lab Struct Chem, Fuzhou 350002, Peoples R ChinaWu, Zhuoxun论文数: 0 引用数: 0 h-index: 0机构: St Johns Univ, Coll Pharm & Hlth Sci, Dept Pharmaceut Sci, Jamaica, NY 11439 USA Chinese Acad Sci, Fujian Inst Res Struct Matter, State Key Lab Struct Chem, Fuzhou 350002, Peoples R ChinaHu, Chaohua论文数: 0 引用数: 0 h-index: 0机构: Fujian Agr & Forestry Univ, Coll Agr, Fuzhou 350002, Peoples R China Chinese Acad Sci, Fujian Inst Res Struct Matter, State Key Lab Struct Chem, Fuzhou 350002, Peoples R ChinaLiao, Dan论文数: 0 引用数: 0 h-index: 0机构: St Johns Univ, Coll Pharm & Hlth Sci, Dept Pharmaceut Sci, Jamaica, NY 11439 USA Guangxi Univ Chinese Med, Key Lab Complementary & Alternat Med Expt Anim Mo, Nanning 530200, Peoples R China Chinese Acad Sci, Fujian Inst Res Struct Matter, State Key Lab Struct Chem, Fuzhou 350002, Peoples R ChinaZhang, Wei论文数: 0 引用数: 0 h-index: 0机构: St Johns Univ, Coll Pharm & Hlth Sci, Dept Pharmaceut Sci, Jamaica, NY 11439 USA Weifang Med Univ, Inst Plast Surg, Weifang, Peoples R China Chinese Acad Sci, Fujian Inst Res Struct Matter, State Key Lab Struct Chem, Fuzhou 350002, Peoples R China论文数: 引用数: h-index:机构:
- [9] The PI3K subunits, P110α and P110β are potential targets for overcoming P-gp and BCRP-mediated MDR in cancer[J]. Molecular Cancer, 19Lei Zhang论文数: 0 引用数: 0 h-index: 0机构: Chinese Academy of Sciences,State Key Laboratory of Structural Chemistry, Fujian Institute of Research on the Structure of MatterYidong Li论文数: 0 引用数: 0 h-index: 0机构: Chinese Academy of Sciences,State Key Laboratory of Structural Chemistry, Fujian Institute of Research on the Structure of MatterQianchao Wang论文数: 0 引用数: 0 h-index: 0机构: Chinese Academy of Sciences,State Key Laboratory of Structural Chemistry, Fujian Institute of Research on the Structure of MatterZhuo Chen论文数: 0 引用数: 0 h-index: 0机构: Chinese Academy of Sciences,State Key Laboratory of Structural Chemistry, Fujian Institute of Research on the Structure of MatterXiaoyun Li论文数: 0 引用数: 0 h-index: 0机构: Chinese Academy of Sciences,State Key Laboratory of Structural Chemistry, Fujian Institute of Research on the Structure of MatterZhuoxun Wu论文数: 0 引用数: 0 h-index: 0机构: Chinese Academy of Sciences,State Key Laboratory of Structural Chemistry, Fujian Institute of Research on the Structure of MatterChaohua Hu论文数: 0 引用数: 0 h-index: 0机构: Chinese Academy of Sciences,State Key Laboratory of Structural Chemistry, Fujian Institute of Research on the Structure of MatterDan Liao论文数: 0 引用数: 0 h-index: 0机构: Chinese Academy of Sciences,State Key Laboratory of Structural Chemistry, Fujian Institute of Research on the Structure of MatterWei Zhang论文数: 0 引用数: 0 h-index: 0机构: Chinese Academy of Sciences,State Key Laboratory of Structural Chemistry, Fujian Institute of Research on the Structure of MatterZhe-Sheng Chen论文数: 0 引用数: 0 h-index: 0机构: Chinese Academy of Sciences,State Key Laboratory of Structural Chemistry, Fujian Institute of Research on the Structure of Matter
- [10] The PI3K p110δ Regulates Expression of CD38 on Regulatory T Cells[J]. PLOS ONE, 2011, 6 (03):Patton, Daniel T.论文数: 0 引用数: 0 h-index: 0机构: Babraham Inst, Lab Lymphocyte Signalling & Dev, Cambridge, England Babraham Inst, Lab Lymphocyte Signalling & Dev, Cambridge, EnglandWilson, Marcus D.论文数: 0 引用数: 0 h-index: 0机构: Babraham Inst, Lab Lymphocyte Signalling & Dev, Cambridge, England Babraham Inst, Lab Lymphocyte Signalling & Dev, Cambridge, EnglandRowan, Wendy C.论文数: 0 引用数: 0 h-index: 0机构: GlaxoSmithKline Res & Dev Ltd, Tool Monoclonal Antibody Grp, Stevenage, Herts, England Babraham Inst, Lab Lymphocyte Signalling & Dev, Cambridge, EnglandSoond, Dalya R.论文数: 0 引用数: 0 h-index: 0机构: Babraham Inst, Lab Lymphocyte Signalling & Dev, Cambridge, England Babraham Inst, Lab Lymphocyte Signalling & Dev, Cambridge, EnglandOkkenhaug, Klaus论文数: 0 引用数: 0 h-index: 0机构: Babraham Inst, Lab Lymphocyte Signalling & Dev, Cambridge, England Babraham Inst, Lab Lymphocyte Signalling & Dev, Cambridge, England